Department of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, P.R. China.
Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Int J Med Sci. 2020 Jan 18;17(3):325-331. doi: 10.7150/ijms.39307. eCollection 2020.
Hairy cell leukemia (HCL) is a rare chronic B-cell lymphoproliferative disorder. It has two pathological subtypes: classical HCL (HCL-C) and HCL-variant (HCL-V). HCL-C and HCL-V are distinct in morphology and immunophenotype. Their differentiation is important for patient management and clinical outcome, with HCL-V responding poorly to conventional HCL treatments. Recently, whole genomic sequencing has been used to identify the difference between HCL-C and HCL-V and mutation of BRAF has been proved to be a molecular hallmark of HCL-C. However, BRAF inhibitors were not effective in all HCL-C cases and HCL-V seems be lack of the high-frequency mutations. Therefore, it is necessary to compare the genomic changes between HCL-C and HCL-V by high-resolution studies, especially in Chinese population, the genomic alterations of HCL have rarely be reported. In this study, the clinical features of a total of 18 Chinese HCL patients were described. Single nucleotide polymorphism (SNP) array analysis was performed to evaluate the genomic copy number alterations (CNA) and copy neutral loss of heterozygosity (CN-LOH) on six HCL-Vs with CD25/BRAF and four HCL-Cs with CD25/BRAF. A total of 24 CNAs including seven chromosomal gains and 17 chromosomal losses, and 22 CN-LOHs were revealed. Five of the six cases of HCL-V showed 15 CNAs including four cryptic chromosomal gains and 11 chromosomal losses. Overlapping regions involving micro-deletion of chromosome 2q13 and large chromosomal loss of 14q were showed in HCL-V. In HCL-C, a total of nine CNAs were revealed in three of the four cases including three chromosomal gains and six chromosomal losses. No overlapping area was observed among the CNVs. 15 CN-LOHs were showed in five of the six cases of HCL-V and seven CN-LOHs was demonstrated in all of the four HCL-Cs. Comparing to Westerners, a relatively higher proportion of HCL-V in all HCL is observed in this study. CNAs and CN-LOHs were common in both HCL-V and HCL-C but the CNAs were different in them. HCL-C was characterized with the higher ratio of large chromosomal changes but lacked of recurrent CNAs, while HCL-V was presented with the higher incidence of cryptic CNAs and recurrent CNAs involving tumor-associated genes. It is necessary to further investigate the association of the genes, such as and genes, and HCL-V in the future study.
毛细胞白血病(Hairy cell leukemia,HCL)是一种罕见的慢性 B 细胞淋巴增殖性疾病。它有两种病理亚型:经典 HCL(HCL-C)和 HCL 变体(HCL-V)。HCL-C 和 HCL-V 在形态学和免疫表型上是不同的。它们的区分对于患者管理和临床结局很重要,因为 HCL-V 对常规 HCL 治疗反应不佳。最近,全基因组测序已被用于识别 HCL-C 和 HCL-V 之间的差异,并且已经证明 BRAF 突变是 HCL-C 的分子标志。然而,BRAF 抑制剂在所有 HCL-C 病例中并不有效,而 HCL-V 似乎缺乏高频突变。因此,有必要通过高分辨率研究比较 HCL-C 和 HCL-V 之间的基因组变化,特别是在中国人中,HCL 的基因组改变很少被报道。在这项研究中,描述了 18 例中国 HCL 患者的临床特征。对 6 例 CD25/BRAF 阳性 HCL-V 和 4 例 CD25/BRAF 阳性 HCL-C 进行单核苷酸多态性(SNP)阵列分析,以评估基因组拷贝数改变(CNA)和拷贝中性杂合性丢失(CN-LOH)。共发现 24 个 CNA,包括 7 个染色体增益和 17 个染色体缺失,以及 22 个 CN-LOH。6 例 HCL-V 中有 5 例显示 15 个 CNA,包括 4 个隐匿性染色体增益和 11 个染色体缺失。在 HCL-V 中显示出涉及染色体 2q13 微缺失和 14q 大片段缺失的重叠区域。在 HCL-C 中,在 4 例中的 3 例中发现了总共 9 个 CNA,包括 3 个染色体增益和 6 个染色体缺失。在 CNVs 之间未观察到重叠区域。在 6 例 HCL-V 中有 5 例显示 15 个 CN-LOH,在所有 4 例 HCL-C 中均显示 7 个 CN-LOH。与西方人相比,本研究中所有 HCL 中 HCL-V 的比例相对较高。HCL-V 和 HCL-C 中均常见 CNA 和 CN-LOH,但它们的 CNA 不同。HCL-C 的特点是大染色体变化的比例较高,但缺乏复发性 CNA,而 HCL-V 则表现为隐匿性 CNA 和复发性 CNA 的发生率较高,涉及肿瘤相关基因。有必要在未来的研究中进一步研究 基因和 基因等基因与 HCL-V 的关联。